Role of chemoreceptors in mediating dyspnea
Introduction
Dyspnea is the uncomfortable awareness of breathing, the sensation of breathlessness or the experience of air hunger (American Thoracic Society, 1999). It is an important clinical symptom used to assess functional status of chronically ill patients with cardiorespiratory or neuromuscular disease, and has thus been the subject of extensive recent reviews (Manning and Mahler, 2001, McConnell and Romer, 2004, O’Donnell et al., 2007). Healthy subjects can experience dyspnea during strenuous exercise, at high altitude, after breath-holding, or during stressful situations that cause anxiety or panic. Dyspnea occurs more frequently in the aged, the obese and the deconditioned. Certain medications can induce dyspnea as a side effect, and it is often the reason cited for cessation of a new medication or for medication non-compliance. It has been a difficult symptom to study, because it is a subjective and uniquely human experience so animal models have limited use in understanding its mechanisms, and it relies on often vague descriptions by patients (American Thoracic Society, 1999).
Dyspnea is a normal phenomenon that is protective against abnormalities in gas exchange. It can be caused by any number of derangements of normal cardiorespiratory function including primary pulmonary, cardiac or neuromuscular diseases. Pulmonary diseases include COPD, asthma, emphysema, interstitial lung disease, pulmonary edema, pulmonary embolism and pulmonary infections. Cardiac diseases include congestive heart failure and acute myocardial infarction (American Thoracic Society, 1999). Neurological diseases commonly leading to dyspnea include, but are not limited to, amyotrophic lateral sclerosis, myasthenia gravis, Guillain-Barré syndrome, multiple sclerosis and Parkinson's disease.
Awareness of respiratory sensation can occur in normal situations or during dyspnea. During dyspnea there is a heightened level of awareness of respiratory sensation and a strong emotional component. The neural basis of dyspnea is therefore likely to involve activation of both the cortex and the limbic system. As will be discussed below there is emerging evidence for cortical and limbic activation associated with dyspnea.
Dyspnea can be induced by an increase in CO2 or decrease in O2. There are several possibilities for how this occurs including direct effects from chemoreceptor activation or indirect effects either through interactions with other respiratory afferents or through activation of corollary discharges. There is evidence in the literature for each of these possibilities; however the specific mechanisms of the chemoreceptor contribution have not yet been elucidated. In order to understand how changes in blood gases cause dyspnea we need to understand how changes in O2 and CO2 are detected, how they influence breathing, and how these changes are transmitted to the forebrain.
Our goal with this review will be fourfold. First we will describe peripheral and central chemoreception and their contribution to the control of breathing. Second, we will describe the evidence that there can be conscious awareness of chemoreceptor input and that this input can induce the sensation of dyspnea. Third, we will speculate as to the mechanisms by which changes in blood gases reach consciousness and how they induce the sensation of dyspnea. Finally, we will discuss chemoreceptor contributions to dyspnea in certain human disease states.
Section snippets
Role of chemoreceptors in breathing
Chemoreceptors are instrumental in the regulation of breathing. Blood concentrations of O2 and CO2 as well as serum pH need to be maintained within a narrow range to ensure normal function of the body's tissues. Changes in the partial pressure of O2 () are sensed primarily by peripheral O2 chemoreceptors. Similarly, small changes in the partial pressure of CO2 () are sensed primarily by central CO2 chemoreceptors. Activation of either chemoreceptor type leads to an increase in
Conscious awareness of blood gases and the role of chemoreceptors in dyspnea
It is well known that intense dyspnea can be induced by breathing a gas mixture with high CO2 or low O2 (American Thoracic Society, 1999). Hypercapnia-induced dyspnea is subjectively more intense than dyspnea induced by voluntary hyperventilation or exercise (Chonan et al., 1990). Dyspnea induced by hypercapnia could theoretically result either directly from activation of chemoreceptors, or indirectly by the increase in respiratory afferent feedback from the resulting increase in respiratory
Mechanisms leading to dyspnea in response to blood gas changes
In order to understand the mechanisms of dyspnea induced by hypercapnia we must define how chemoreceptor activation can directly or indirectly activate the forebrain.
Chemoreceptors and dyspnea in human disease
Chemoreceptors likely contribute to the sensation of dyspnea in normal, healthy individuals in some circumstances, but there are certain disease entities in which activation of chemoreceptors may be of particular relevance.
Summary
Dyspnea is a multifactorial sensation involving interplay of sensory afferent information onto the central respiratory control nuclei and connections to and from higher cortical and limbic centers (Fig. 5). Chemoreceptors certainly play a role in the sensation of dyspnea, likely via a combination of (1) increasing respiratory output and subsequent respiratory afferent activation, (2) activation of corollary discharges and (3) direct projections from chemoreceptors to forebrain
Acknowledgements
Supported by the NICHD, the VAMC, and the Bumpus Foundation.
References (151)
- et al.
‘Air hunger’ from increased persists after complete neuromuscular block in humans
Respir. Physiol.
(1990) - et al.
’Air hunger’ arising from increased in mechanically ventilated quadriplegics
Respir. Physiol.
(1989) - et al.
Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered
Exp. Neurol.
(2008) - et al.
Staging of brain pathology related to sporadic Parkinson's disease
Neurobiol. Aging
(2003) - et al.
Respiratory-associated thalamic activity is related to level of respiratory drive
Respir. Physiol.
(1992) A cognitive approach to panic
Behav. Res. Ther.
(1986)- et al.
Brain circuits in panic disorder
Biol. Psychiatry
(1998) - et al.
Unit activity in the hypothalamus and the sympathetic response to hypoxia and hypercapnia
Exp. Neurol.
(1963) - et al.
Depolarization and stimulation of neurons in nucleus tractus solitarii by carbon dioxide does not require chemical synaptic input
Neuroscience
(1990) - et al.
Cell-cell coupling in CO(2)/H(+)-excited neurons in brainstem slices
Respir. Physiol.
(2001)